Andrey Zuskov, MD
Orthopaedic Surgery · Houston, TXNPI 1053738476
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (34.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Smith+Nephew at 34.6% of the total. Reporting peaked in 2023 at $16,654 and has fallen 70.1% since, to $4,972 in 2025.
Across 158 payments — averaging $258.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$14K
- Stryker$8K
- Arthrex$7K
- Medacta USA, Inc.$5K
- Medtronic$3K
- Medical Device Business Services, Inc.$2K
- plus $3K from 9 others
What the payments were for
- Speaking & faculty fees$1070%
- Grants$6,66716%
- Travel & lodging$11,54628%
- Food & beverage$8,59421%
- Education$13,98734%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 8 | $14,168 |
| Stryker(2 entities) | 52 | $7,515 |
| Arthrex | 1 | $6,667 |
| Medacta USA, Inc. | 18 | $4,664 |
| Medtronic | 33 | $2,975 |
| Medical Device Business Services, Inc. | 16 | $1,712 |
| Orthalign Inc | 9 | $1,304 |
| Zimmer Biomet | 12 | $1,228 |
| Illuminoss Medical, Inc. | 1 | $204 |
| Organogenesis Inc. | 2 | $149 |
| Skeletal Dynamics Inc | 1 | $104 |
| Endo Pharmaceuticals Inc. | 1 | $101 |
| Johnson & Johnson | 2 | $70 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Supreme Orthopedic Systems, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$4,777
- GMK SPHERE$3,430
- AQUAMANTYS$1,733
- ORTHALIGN PLUS$1,248
- ACTIS$1,117
- ATTUNE$1,117
- AEQUALIS$1,017
- Persona$804
- AMISTEM$797
- REAL INTELLIGENCE$372
- POWEREASE INSTRUMENTS$289
- ROSA$266
- Journey II$220
- Photodynamic Bone Stabilization Procedure Pack$204
- RESTORATION$171
- INSIGNIA$163
- T2$161
- K-15 PORK$152
- mymobility Platform$146
- 1788$136
How this compares
$40,901 in reported general payments places this provider in the 85th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 13 | $99 |
| Gabapentin | 11 | $66 |
| Meloxicam | 19 | $33 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Houston
- Stefan KreuzerHouston$6.2M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- Adam FreedhandHouston$1.8M
- Jeffrey KozakHouston$1.1M
- Travis HansonHouston$1M
- Thomas TanousHouston$698K
- Alan RechterHouston$605K
- Ugonna IhekweazuHouston$544K
- Darrell HansonHouston$284K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.